- Resource
- BR1DGE
- Infographic
- Management
- Pathophysiology
The Importance of C-peptide in Autoimmune T1D
An infographic summarising C-peptide, a key biomarker of beta-cell function.
Learning Objectives
- Understand that C-peptide is a byproduct of insulin synthesis
- Recognize C-peptide's role in understanding disease status in T1D
- Appreciate C-peptide's potential as a diagnostic and prognostic tool
Summary
C-peptide is a key tool in autoimmune type 1 diabetes (T1D) management. It aids diagnosis, disease monitoring, and is a key biomarker for beta-cell function and endogenous insulin secretion. C-peptide measurement during a mixed-meal tolerance test is the gold standard for assessing beta-cell function. Residual C-peptide predicts positive outcomes, fewer diabetes-related complications, and improved glycemic control, meaning C-peptide can potentially guide early interventions to delay or prevent the clinical onset of T1D.
.svg){kind=small}
MAT-GLB-2503049 - 1.0 - 09/2025
The Importance of Preserving Residual Beta-Cell Function in T1D
Maintaining residual beta-cell function in T1D improves glycemic control, reduces complications, and impacts care and outcomes in people with T1D.
Early T1D Screening Recommendations
Expert insights on recommendations for T1D screening, including proposed age ranges and opportunities for integration into existing public health touchpoints.
Supporting islet-autoantibody-positive individuals and their families
Appropriate strategies can help support people with early-stage T1D and their families and address anxiety during early T1D monitoring, ensuring optimal engagement and care.